Transplant center directory

Established in January 2000, the BMT program at UCSF Benioff Children's Hospital Oakland provides a comprehensive range of pediatric and young adult transplant and cellular therapy services in the San Francisco Bay Area, including referrals throughout northern California, nationally and internationally. Our comprehensive services are available throughout the transplant trajectory of care and include donor evaluation, recipient evaluation, intra-transplant care, donor collection, post-transplant care in a pediatric and young adult outpatient facility, and photopheresis for acute and chronic graft versus host disease. The center has now also expanded its care giving by participating in transplantation clinical trials and commercial products for patients with hemoglobinopathies (e.g., sickle cell and thalassemia)

This center has been performing allogeneic transplants since 2000 and has been an NMDP/Be The Match transplant center since June 2002.

This center's actual 1-year survival results are similar to the expected rate for this center.

The survival information we have for this center includes ONLY:

1. Patients who had their FIRST ALLOGENEIC transplant (cells from a related or unrelated donor/cord blood) during 2019, 2020, 2021, and
2. Who had their transplant at a U.S. transplant center, and
3. Who had follow-up information provided by the transplant center for analysis

For this center, we have survival information for 23 patients.

The actual 1-year survival of these patients is 95.7%.

Compared to similar patients transplanted at all centers in the U.S., we expect that the 1-year survival for patients at this center to be in a range between 73.0% and 99.1%.

For help with understanding these statistics, please see Understanding Transplant Outcomes.

For overall survival for all patients transplanted with a specific disease, please see U.S. Patient Survival report at bloodcell.transplant.hrsa.gov.

All diseases

Number of transplants by age reported from January 1, 2021 to December 31st, 2022 (includes marrow, PBSC and cord blood)

Treatments may be similar for diseases within a group. It might be helpful to look at centers that have done transplants for a specific disease and centers that have done transplants for any corresponding broad disease categories.